{
    "root": "280569a4-e524-4374-8549-97be20e4fb33",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "XPOVIO",
    "value": "20250313",
    "ingredients": [
        {
            "name": "selinexor",
            "code": "31TZ62FO8F"
        },
        {
            "name": "Microcrystalline Cellulose 101",
            "code": "7T9FYH5QMK"
        },
        {
            "name": "Microcrystalline Cellulose 102",
            "code": "PNR0YF693Y"
        },
        {
            "name": "Croscarmellose Sodium",
            "code": "M28OL1HH48"
        },
        {
            "name": "Povidone K30",
            "code": "U725QWY32X"
        },
        {
            "name": "Sodium Lauryl Sulfate",
            "code": "368GB5141J"
        },
        {
            "name": "Silicon Dioxide",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "Magnesium Stearate",
            "code": "70097M6I30"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "GLYCERYL MONOSTEARATE",
            "code": "230OU9XXE4"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "FD&C BLUE NO. 2--ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        }
    ],
    "indications": "xpovio nuclear export inhibitor indicated : combination bortezomib dexamethasone treatment adult patients multiple myeloma received least one prior therapy ( 1.1 ) . combination dexamethasone treatment adult patients relapsed refractory multiple myeloma received least four prior therapies whose disease refractory least two proteasome inhibitors , least two immunomodulatory agents , anti-cd38 monoclonal antibody ( 1.1 ) . treatment adult patients relapsed refractory diffuse large b-cell lymphoma ( dlbcl ) , otherwise specified , including dlbcl arising follicular lymphoma , least 2 lines systemic therapy . indication approved accelerated approval based response rate . continued approval indication may contingent upon verification description benefit confirmatory trial ( ) ( 1.2 ) .",
    "contraindications": "multiple myeloma combination bortezomib dexamethasone ( xvd ) : recommended xpovio 100 mg taken orally weekly combination bortezomib dexamethasone ( 2.1 ) . multiple myeloma combination dexamethasone ( xd ) : recommended xpovio 80 mg taken orally days 1 3 week combination dexamethasone ( 2.1 ) . dlbcl : recommended xpovio 60 mg taken orally days 1 3 week ( 2.2 ) .",
    "warningsAndPrecautions": "xpovio 10 mg tablets blue , round , bi-convex , film-coated debossed \u201c x10 \u201d one side nothing side . xpovio 20 mg tablets blue , round , bi-convex , film-coated debossed \u201c k20 \u201d one side nothing side . xpovio 40 mg tablets blue , oval , film-coated , debossed sides \u201c x40 \u201d . xpovio 50 mg tablets blue , oval , film-coated , debossed sides \u201c x50 \u201d . xpovio 60 mg tablets blue , oval , film-coated , debossed sides \u201c x60 \u201d . tablets packaged child-resistant blister pack . four blister packs supplied per carton . following thirteen dose presentations available : weekly dose strength per tablet carton ( 28 day supply ) blister pack ndc 80 mg twice weekly 20 mg 4 blister packs ( 32 tablets total thecarton ) blister eight 20 mg tablets outer carton ndc72237-101-04 blister pack ndc72237-101-14 60 mg twice weekly 20 mg 4 blister packs ( 24 tablets total thecarton ) blister six 20 mg tablets outer carton ndc72237-101-03 blister pack ndc72237-101-13 100 mg weekly 20 mg 4 blister packs ( 20 tablets total thecarton ) blister five 20 mg tablets outer carton ndc72237-101-05 blister pack ndc72237-101-15 80 mg weekly 20 mg 4 blister packs ( 16 tablets total thecarton ) blister four 20 mg tablets outer carton ndc72237-101-02 blister pack ndc72237-101-12 40 mg twice weekly 20 mg 4 blister packs ( 16 tablets total thecarton ) blister four 20 mg tablets outer carton ndc72237-101-06 blister pack ndc72237-101-16 60 mg weekly 20 mg 4 blister packs ( 12 tablets total thecarton ) blister three 20 mg tablets outer carton ndc72237-101-01 blister pack ndc72237-101-11 40 mg weekly 20 mg 4 blister packs ( 8 tablets total carton ) blister two 20 mg tablets outer carton ndc72237-101-07 blister pack ndc72237-101-17 100 mg weekly 50 mg 4 blister packs ( 8 tablets total carton ) blister two 50 mg tablets outer carton ndc 72237-103-05 blister pack ndc72237-103-15 80 mg weekly 40 mg 4 blister packs ( 8 tablets total carton ) blister two 40 mg tablets outer carton ndc 72237-102-02 blister pack ndc72237-102-12 40 mg twice weekly 40 mg 4 blister packs ( 8 tablets total carton ) blister two 40 mg tablets outer carton ndc72237-102-06 blister pack ndc72237-102-16 60 mg weekly 60 mg 4 blister packs ( 4 tablets total carton ) blister one 60 mg tablet outer carton ndc72237-104-01 blister pack ndc72237-104-11 40 mg weekly 40 mg 4 blister packs ( 4 tablets total carton ) blister one 40 mg tablet outer carton ndc72237-102-07 blister pack ndc72237-102-17 40 mg weekly 10 mg 4 blister packs ( 16 tablets total carton ) blister four 10 mg tablets outer carton ndc72237-106-01 blister pack ndc72237-106-11 store 30\u00b0c ( 86\u00b0f ) .",
    "adverseReactions": "none .",
    "indications_original": "XPOVIO is a nuclear export inhibitor indicated: In combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy ( 1.1 ). In combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody ( 1.1 ). For the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy. This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s) ( 1.2 ).",
    "contraindications_original": "Multiple Myeloma in Combination with Bortezomib and Dexamethasone (XVd): Recommended dosage of XPOVIO is 100 mg taken orally once weekly in combination with bortezomib and dexamethasone ( 2.1 ). Multiple Myeloma in Combination with Dexamethasone (Xd): Recommended dosage of XPOVIO is 80 mg taken orally on Days 1 and 3 of each week in combination with dexamethasone ( 2.1 ). DLBCL: Recommended dosage of XPOVIO is 60 mg taken orally on Days 1 and 3 of each week ( 2.2 ).",
    "warningsAndPrecautions_original": "XPOVIO 10 mg tablets are blue, round, bi-convex, film-coated debossed with \u201cX10\u201d on one side and nothing on the other side.\n\n                  XPOVIO 20 mg tablets are blue, round, bi-convex, film-coated debossed with \u201cK20\u201d on one side and nothing on the other side.\n\n                  XPOVIO 40 mg tablets are blue, oval, film-coated, debossed on both sides with \u201cX40\u201d.\n\n                  XPOVIO 50 mg tablets are blue, oval, film-coated, debossed on both sides with \u201cX50\u201d.\n\n                  XPOVIO 60 mg tablets are blue, oval, film-coated, debossed on both sides with \u201cX60\u201d.\n\n                  Tablets are packaged in a child-resistant blister pack. Four blister packs are supplied per carton. The following thirteen dose presentations are available:\n\n                  \n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              Weekly dose\n                           \n                           \n                              Strength per tablet\n                           \n                           \n                              Carton (28 day supply)\n                           \n                           \n                              Blister Pack\n                           \n                           \n                              NDC\n                           \n                        \n                        \n                           80 mg twice weekly\n\n                           20 mg\n\n                           4 blister packs(32 tablets total in thecarton)\n\n                           Each blister has eight 20 mg tablets\n\n                           Outer carton NDC72237-101-04\n                              Blister pack NDC72237-101-14\n\n                        \n                        \n                           60 mg twice weekly\n\n                           20 mg\n\n                           4 blister packs(24 tablets total in thecarton)\n\n                           Each blister has six 20 mg tablets\n\n                           Outer carton NDC72237-101-03\n                              Blister pack NDC72237-101-13\n\n                        \n                        \n                           100 mg once weekly\n\n                           20 mg\n\n                           4 blister packs(20 tablets total in thecarton)\n\n                           Each blister has five 20 mg tablets\n\n                           Outer carton NDC72237-101-05\n                              Blister pack NDC72237-101-15\n\n                        \n                        \n                           80 mg once weekly\n\n                           20 mg\n\n                           4 blister packs(16 tablets total in thecarton)\n\n                           Each blister has four 20 mg tablets\n\n                           Outer carton NDC72237-101-02\n                              Blister pack NDC72237-101-12\n\n                        \n                        \n                           40 mg twice weekly\n\n                           20 mg\n\n                           4 blister packs(16 tablets total in thecarton)\n\n                           Each blister has four 20 mg tablets\n\n                           Outer carton NDC72237-101-06\n                              Blister pack NDC72237-101-16\n\n                        \n                        \n                           60 mg once weekly\n\n                           20 mg\n\n                           4 blister packs(12 tablets total in thecarton)\n\n                           Each blister has three 20 mg tablets\n\n                           Outer carton NDC72237-101-01\n                              Blister pack NDC72237-101-11\n\n                        \n                        \n                           40 mg once weekly\n\n                           20 mg\n\n                           4 blister packs(8 tablets total in the carton)\n\n                           Each blister has two 20 mg tablets\n\n                           Outer carton NDC72237-101-07\n                              Blister pack NDC72237-101-17\n\n                        \n                        \n                           100 mg once weekly\n\n                           50 mg\n\n                           4 blister packs(8 tablets total in the carton)\n\n                           Each blister has two 50 mg tablets\n\n                           Outer carton NDC 72237-103-05\n                              Blister pack NDC72237-103-15\n\n                        \n                        \n                           80 mg once weekly\n\n                           40 mg\n\n                           4 blister packs(8 tablets total in the carton)\n\n                           Each blister has two 40 mg tablets\n\n                           Outer carton NDC 72237-102-02\n                              Blister pack NDC72237-102-12\n\n                        \n                        \n                           40 mg twice weekly\n\n                           40 mg\n\n                           4 blister packs(8 tablets total in the carton)\n\n                           Each blister has two 40 mg tablets\n\n                           Outer carton NDC72237-102-06\n                              Blister pack NDC72237-102-16\n\n                        \n                        \n                           60 mg once weekly\n\n                           60 mg\n\n                           4 blister packs(4 tablets total in the carton)\n\n                           Each blister has one 60 mg tablet\n\n                           Outer carton NDC72237-104-01\n                              Blister pack NDC72237-104-11\n\n                        \n                        \n                           40 mg once weekly\n\n                           40 mg\n\n                           4 blister packs(4 tablets total in the carton)\n\n                           Each blister has one 40 mg tablet\n\n                           Outer carton NDC72237-102-07\n                              Blister pack NDC72237-102-17\n\n                        \n                        \n                           40 mg once weekly\n\n                           10 mg\n\n                           4 blister packs(16 tablets total in the carton)\n\n                           Each blister has four 10 mg tablets\n\n                           Outer carton NDC72237-106-01\n                              Blister pack NDC72237-106-11\n\n                        \n                     \n                  \n                  Store at or below 30\u00b0C (86\u00b0F).",
    "adverseReactions_original": "None."
}